<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01405690</url>
  </required_header>
  <id_info>
    <org_study_id>08-0033-BE</org_study_id>
    <nct_id>NCT01405690</nct_id>
  </id_info>
  <brief_title>The Role Of Noninvasive 320-Row Multidetector Computer Tomography</brief_title>
  <official_title>A Pilot Study: The Role Of Noninvasive 320-Row Multidetector Computer Tomography Coronary Angiogram In Predicting Perioperative Cardiac Complications In Patients Referred For Noncardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mount Sinai Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Computer tomography coronary angiogram (CTCA) has emerged as a noninvasive alternative to&#xD;
      assessing coronary artery luminal disease. Although the use of noninvasive CTCA for the&#xD;
      detection of coronary artery disease is on the rise, the current technology of the 64-row&#xD;
      multidetector computer tomography (MDCT) is subjected to multiple patient artifacts that can&#xD;
      affect image quality.To eliminate these patient related artifacts a more advanced 320-row&#xD;
      MDCT was recently developed. The investigators therefore propose that the newly developed&#xD;
      320-MDCT can provide an accurate noninvasive assessment of the severity of coronary artery&#xD;
      luminal stenosis as an alternative to an invasive coronary angiogram.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study consisting of a prospective non-randomized observational trial where a team&#xD;
      of surgeon, anesthesiologist, and evaluator are blinded to CTCA results. We hypothesize that&#xD;
      the preoperative use of noninvasive computer tomography, with the 320-row MDCT, to visualize&#xD;
      the degree of coronary artery stenosis can lead to improved clinical prediction of&#xD;
      perioperative cardiac complications.&#xD;
&#xD;
      The 320-row MDCT is based on the 64-row technology with the significant addition of a larger&#xD;
      detector capable of scanning the heart within 1 sec or a cardiac cycle, thereby, eliminating&#xD;
      patient-related artifacts and may produce higher image quality.13, 14 The scanning time of 5&#xD;
      seconds with the 320-row MDCT is significantly reduced compared to 8-10 seconds for the&#xD;
      64-row MDCT&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the coronary luminal stenosis for location, number of vessels involved and severity of luminal stenosis using noninvasive CTCA.</measure>
    <time_frame>CTCA 1-2 hours</time_frame>
    <description>CTCA will be read by a cardiac radiologist blinded to the patients' medical/cardiac history and the results of the stress test. The cardiac radiologist will classify the severity of coronary artery disease according to number of vessels, location and degree of luminal steno-occlusive disease.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative cardiac complications</measure>
    <time_frame>In hospital day 0-3, 30 days post surgery and one year</time_frame>
    <description>Non-fatal and fatal cardiac complications will be reviewed day 0- 3 and day 30 post-surgery and one year. Patients who are discharged home will be contacted by telephone by a research assistant for post-operative follow-up. Non-fatal cardiac complications include myocardial infarction, arrythmias, electrocardiogram ischemic changes, cardiac enzymes elevation, symptoms of congestive heart failure and/or angina</description>
  </secondary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Coronary Artery Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        - stable patients undergoing intermediate or high risk elective non-cardiac surgical&#xD;
        procedure according to the American Heart Association/American College of Cardiology&#xD;
        (AHA/ACC) Guideline for Perioperative Cardiovascular Evaluation for Non-Cardiac Surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female, 18 years and older&#xD;
&#xD;
          -  Able to understand and willing to sign the Informed Consent Form&#xD;
&#xD;
          -  Undergoing vascular surgery or intermediate risk surgery (these include&#xD;
             intraperitoneal, intrathoracic, carotid endarterectomy , head and neck, orthopedics or&#xD;
             prostate) AND&#xD;
&#xD;
          -  One or more of the following clinical predictors according to the Revised Cardiac Risk&#xD;
             Index:&#xD;
&#xD;
               1. history of ischemic heart disease (CABG, MI, Stent, positive stress test, Q-waves&#xD;
                  on ECG)&#xD;
&#xD;
               2. Diabetes (requiring insulin)&#xD;
&#xD;
               3. history of congestive heart failure (NYHA I- II)&#xD;
&#xD;
               4. history of cerebrovascular disease, any of :&#xD;
&#xD;
                    1. history of carotid stenosis&#xD;
&#xD;
                    2. history of ischemic cerebrovascular disease (stroke or TIA)&#xD;
&#xD;
               5. Aortic or peripheral vascular disease OR&#xD;
&#xD;
               6. Risk of CAD with 3 or more of the following&#xD;
&#xD;
                    1. Age â‰¥ 70 years&#xD;
&#xD;
                    2. Hypertension (medicated)&#xD;
&#xD;
                    3. Cholesterol (medicated)&#xD;
&#xD;
                    4. Diabetes (medicated-oral hypoglycemic)&#xD;
&#xD;
                    5. Family history of coronary artery disease&#xD;
&#xD;
                       -&#xD;
&#xD;
                       Exclusion Criteria:&#xD;
&#xD;
                         1. Lack of consent for participation&#xD;
&#xD;
                         2. Pregnancy&#xD;
&#xD;
                         3. History of an allergic response to iodinated contrast medium&#xD;
&#xD;
                         4. History of an allergic response, or other contraindication to beta&#xD;
                            blockers&#xD;
&#xD;
                         5. eGFR &lt; 45 mL/min&#xD;
&#xD;
                         6. Hemodynamically unstable/compromised&#xD;
&#xD;
                         7. Urgent surgery&#xD;
&#xD;
                         8. Atrial fibrillation &gt; 80 bpm&#xD;
&#xD;
                         9. Uncontrolled tachyarrhythmia&#xD;
&#xD;
                        10. Atrioventricular block (second and third degree)&#xD;
&#xD;
                        11. Moderate to severe aortic stenosis&#xD;
&#xD;
                        12. Not able to hold breath for 5 - 10 seconds&#xD;
&#xD;
                        13. History of multiple myeloma or organ transplant&#xD;
&#xD;
                        14. Severe pulmonary disease including COPD, PAH, asthma&#xD;
&#xD;
                        15. Congestive heart failure presented as NYHA functional class III - IV&#xD;
&#xD;
                        16. Severe anemia&#xD;
&#xD;
                        17. Increased intracranial pressure&#xD;
&#xD;
                        18. Closed angle glaucoma&#xD;
&#xD;
                        19. Absolute contraindication to Nitroglycerin&#xD;
&#xD;
                        20. Presence of medical condition or history that investigator feels would&#xD;
                            be problematic&#xD;
&#xD;
                        21. Acute myocardial infarction (within 4-6 weeks) -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric You Ten Kong, MD PhD FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Hospital, University Health Network</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Heatlh Network, Mount Sinai, Toronto General Hopsital sites</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>July 27, 2011</study_first_submitted>
  <study_first_submitted_qc>July 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2011</study_first_posted>
  <last_update_submitted>December 2, 2016</last_update_submitted>
  <last_update_submitted_qc>December 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CAD</keyword>
  <keyword>CTCA</keyword>
  <keyword>multidetector computer tomography (MDCT)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

